A. Lago

Influence of Intestinal Helminth Burden on Clinical Manifestations, Therapeutic Response, and Leishmania braziliensis Load in Patients with New World Cutaneous Leishmaniasis.

E. Carvalho, M. Glesby, A. Schriefer, 2021, The American journal of tropical medicine and hygiene.

The skin microbiome enhances disease through IL-1β and delays healing in cutaneous leishmaniasis patients

E. Grice, D. Beiting, C. Farias Amorim, 2023, medRxiv.

Selective whole-genome amplification reveals population genetics of Leishmania braziliensis directly from patient skin biopsies

Yun S. Song, Jane A. Yu, Alexander S. F. Berry, 2022, medRxiv.

The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.

A. M. Carvalho, M. Wilson, L. Carvalho, 2018, The American journal of tropical medicine and hygiene.

Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-γ signature

D. Beiting, C. Farias Amorim, P. Scott, 2021, PLoS neglected tropical diseases.

Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-γ signature

C. Amorim, D. Beiting, P. Scott, 2020, medRxiv.

Unbalanced production of LTB4/PGE2 driven by diabetes increases susceptibility to cutaneous leishmaniasis

C. Brodskyn, L. Carvalho, E. Carvalho, 2020, Emerging microbes & infections.

Diabetes Modifies the Clinic Presentation of Cutaneous Leishmaniasis

A. M. Carvalho, Alexsandro S Lago, L. Carvalho, 2020, Open forum infectious diseases.

Multi-omic Analyses of Plasma Cytokines, Lipidomics, and Transcriptomics Distinguish Treatment Outcomes in Cutaneous Leishmaniasis

C. Sorgi, L. Faccioli, P. Bozza, 2020, iScience.

Influence of Obesity on Clinical Manifestations and Response to Therapy in Cutaneous Leishmaniasis caused by Leishmania braziliensis.

A. M. Carvalho, L. Carvalho, E. Carvalho, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.